235 related articles for article (PubMed ID: 33614954)
1. Survey of Pharmacists' Knowledge of Connecticut's Medical Cannabis Program.
Reece SM; Holle L; Mukherjee K
Cannabis Cannabinoid Res; 2021; 6(1):66-73. PubMed ID: 33614954
[No Abstract] [Full Text] [Related]
2. Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch.
Hwang J; Arneson T; St Peter W
P T; 2016 Nov; 41(11):716-722. PubMed ID: 27904305
[TBL] [Abstract][Full Text] [Related]
3. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.
Szaflarski M; McGoldrick P; Currens L; Blodgett D; Land H; Szaflarski JP; Segal E
Epilepsy Behav; 2020 Aug; 109():107102. PubMed ID: 32442891
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.
Bawa Z; Saini B; McCartney D; Bedoya-Pérez M; McLachlan AJ; McGregor IS
Int J Clin Pharm; 2023 Apr; 45(2):375-386. PubMed ID: 36446995
[TBL] [Abstract][Full Text] [Related]
5. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM; Sherman EM; Shafiq S; Hardigan P
J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
[TBL] [Abstract][Full Text] [Related]
6. Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey.
Slawek DE; Althouse AD; Feldman R; Arnsten JH; Bulls HW; Liebschutz JM; Nugent SM; Orris SR; Rohac R; Starrels JL; Morasco BJ; Kansagara D; Merlin JS
BMC Prim Care; 2023 Jul; 24(1):145. PubMed ID: 37442944
[TBL] [Abstract][Full Text] [Related]
7. A survey of Wisconsin pharmacists about cannabinoid products: Are we ready to recommend?
Emmerling S; Martin B; Schmitz N
J Am Pharm Assoc (2003); 2021; 61(6):e71-e75. PubMed ID: 34456146
[TBL] [Abstract][Full Text] [Related]
8. Arkansas community's attitudes toward the regulation of medical cannabis and the pharmacist's involvement in Arkansas medical cannabis.
Gladden ME; Hung D; Bhandari NR; Franks AM; Russell L; White L; Fantegrossi WE; Payakachat N
J Am Pharm Assoc (2003); 2020; 60(1):235-243. PubMed ID: 31831352
[TBL] [Abstract][Full Text] [Related]
9. Pharmacists' attitudes regarding provision of sexual and reproductive health services.
Hilverding AT; DiPietro Mager NA
J Am Pharm Assoc (2003); 2017; 57(4):493-497. PubMed ID: 28619391
[TBL] [Abstract][Full Text] [Related]
10. Pharmacists' knowledge and interest in developing counseling skills relating to oral contraceptives.
Amin ME
Int J Clin Pharm; 2016 Apr; 38(2):395-403. PubMed ID: 26873480
[TBL] [Abstract][Full Text] [Related]
11. Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis.
Merlin JS; Althouse A; Feldman R; Arnsten JH; Bulls HW; Liebschutz JM; Nugent SM; Orris SR; Rohac R; Starrels JL; Morasco BJ; Kansagara D
JAMA Netw Open; 2021 Sep; 4(9):e2124511. PubMed ID: 34524435
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacists' knowledge of and attitudes toward oral chemotherapy.
O'Bryant CL; Crandell BC
J Am Pharm Assoc (2003); 2008; 48(5):632-9. PubMed ID: 18826902
[TBL] [Abstract][Full Text] [Related]
13. Continuing professional development in Texas: survey of pharmacists' knowledge and attitudes: 2008.
Bellanger RA; Shank TC
J Am Pharm Assoc (2003); 2010; 50(3):368-74. PubMed ID: 20452910
[TBL] [Abstract][Full Text] [Related]
14. A nationwide survey of pharmacy students' knowledge and perceptions regarding medical cannabis.
Moeller KE; McGuire JM; Melton BL
J Am Pharm Assoc (2003); 2020; 60(1):218-224.e3. PubMed ID: 31585701
[TBL] [Abstract][Full Text] [Related]
15. Reefer madness or real medicine? A plea for incorporating medicinal cannabis in pharmacy curricula.
Abazia DT; Bridgeman MB
Curr Pharm Teach Learn; 2018 Sep; 10(9):1165-1167. PubMed ID: 30497617
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
17. The use of an integrated opioid and medical marijuana prescription drug monitoring program.
Rickles NM; Wakai S; Karim-Nejad L
J Am Pharm Assoc (2003); 2021; 61(4):408-417. PubMed ID: 33903060
[TBL] [Abstract][Full Text] [Related]
18. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
Okoro O; Hillman L
J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
[TBL] [Abstract][Full Text] [Related]
19. Examining community-based pharmacist perceptions on the care of transgender patients.
Aragon KG; Conklin J; Lenell A; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S62-S66. PubMed ID: 31203014
[TBL] [Abstract][Full Text] [Related]
20. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey.
Corroon J; Sexton M; Bradley R
BMC Fam Pract; 2019 Dec; 20(1):174. PubMed ID: 31837706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
